Trimethylammonium

Trimethylammonium

SCHEMBL6907735

CN(C)C.Oc1ccc(Cl)c2ccccc12

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 7/20 0.56
CYP1A2 P05177 2/20 0.56
CYP2A6 P11509 2/20 0.56
EP300 Q09472 3/20 0.53
KAT2B Q92831 3/20 0.53
KAT8 Q9H7Z6 3/20 0.53
TSHR P16473 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
LMNA P02545 2/20 0.46
KDM4E B2RXH2 2/20 0.46
MAPT P10636 2/20 0.46
BRD4 O60885 1/20 0.46
HSP90AA1 P07900 1/20 0.46
METAP2 P50579 1/20 0.46
METAP1 P53582 1/20 0.46
HDAC3 O15379 1/20 0.45
NCOR2 Q9Y618 1/20 0.45
KMT2A Q03164 1/20 0.42
ATM Q13315 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Alcohol SCHEMBL27450925 0.91 IDO1 (0.62) IDO1CYP1A2CYP2A6EP300KAT2B
SCHEMBL3935 0.91 IDO1 (0.68) IDO1CYP1A2CYP2A6EP300KAT2B
Hydrogen Peroxide SCHEMBL9131999 0.89 IDO1 (0.65) IDO1CYP1A2CYP2A6EP300KAT2B
Methylsulfanylmethane SCHEMBL4410531 0.87 IDO1 (0.56) IDO1CYP1A2CYP2A6EP300KAT2B
SCHEMBL4960152 0.77 CYP1A2 (0.68) IDO1CYP1A2CYP2A6EP300KAT2B
SCHEMBL5530591 0.76 PTPN22 (0.48) IDO1CYP1A2CYP2A6EP300KAT2B
SCHEMBL29494605 0.75 CYP2A6 (1.00) CYP1A2CYP2A6TSHRNPC1RAB9A
SCHEMBL29638 0.75 IDO1 (1.00) IDO1CYP1A2EP300KAT2BKAT8
SCHEMBL29362983 0.75 IDO1 (1.00) IDO1CYP1A2EP300KAT2BKAT8
SCHEMBL32677325 0.75 IDO1 (1.00) IDO1CYP1A2EP300KAT2BKAT8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040053893-A1 Method of assaying iysophospholipase d activity AZWELL INC. (JP) 2004-03-18 US disclosed
EP-1357126-A1 METHOD OF ASSAYING LYSOPHOSPHOLIPASE D ACTIVITY Azwell Inc. (JP) 2003-10-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040053893-A1 Method of assaying iysophospholipase d activity LYPLA1, LPL, LYPLA2 IDO1 481/4885CYP1A2 2110/4885CYP2A6 1467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.